George Soros’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

George Soros’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-116,588	Closed	-$15.4M	–	282
2025 Q1	$15.4M	Buy	+116,588	New	+$14.5M	0.23%	110
2017 Q4	–	Sell	-114,000	Closed	-$1.8M	–	284
2017 Q3	$1.8M	Buy	+114,000	New	+$1.67M	0.04%	131

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

George Soros's ITCI Position: Q2 2025 in Review

George Soros sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 116,588 shares — an estimated $15.4M sold.

George Soros first reported a position in ITCI in Q3 2017 and held it in 2 quarters. The position peaked at $15.4M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

George Soros reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
George Soros sold 116,588 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $15.4M.
George Soros first reported a position in Intra-Cellular Therapies Inc. in Q3 2017 and held it in 2 quarters.
George Soros's Intra-Cellular Therapies Inc. position peaked at $15.4M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Soros Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.